Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of BHV-3241 in Subjects With Multiple System Atrophy (M-STAR Study)
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of BHV-3241 in Subjects With Multiple System Atrophy (M-STAR Study)
The purpose of this study is to compare the efficacy of verdiperstat (BHV-3241) versus placebo in participants with Multiple System Atrophy
Inclusion Criteria:
Exclusion Criteria:
Boca Raton, Florida 33486, United States
Philadelphia, Pennsylvania 19107, United States
Rennes, 35033, France
Strasbourg, 67098, France
Marburg, 35043, Germany